Moffitt Study Shows How Cancer Cell Death May Harm the Immune System and Promote Tumor Growth

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell death can actually make tumors grow faster by turning off the immune system’s ability to fight the cancer.

Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.

New study shows how salmonella tricks gut defenses to cause infection

A study led by UC Davis distinguished professor Andreas Bäumler uncovered how Salmonella, a major cause of food poisoning, can invade the gut despite the presence of protective bacteria.

Editorial Warns of Heart Disease Risks Associated with Yo-Yo Dieting

A new editorial – published in Nature – suggests that frequent fluctuations in diet, commonly known as “yo-yo dieting,” can significantly increase the risk of cardiovascular disease. The authors, from the University of Pennsylvania Schools of Nursing and Medicine, describe how cycling between high-fat and low-fat diets in mice led to a substantial acceleration of atherosclerosis, a condition characterized by the buildup of plaque in arteries.

National Multiple Sclerosis Society awards $1M to Case Western Reserve University researchers to study new approach to treat the disease

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide. In MS, the immune system mistakenly attacks the myelin sheath—a protective layer surrounding nerve cells in the nervous system. The loss of myelin, combined with ongoing inflammation, causes dysfunction and death of nerve cells, making the disability worse, such as difficulties with movement, coordination, and sensation. Treatments now focus on reducing attacks on myelin, but don’t address nerve-cell damage and death. But with $1 million from the National Multiple Sclerosis Society (NMSS), a research team co-led by Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics and director of the Institute for Glial Sciences, and Ben Clayton, assistant professor and founding member of the Institute for Glial Sciences, both in the Department of Genetics and Genome Sciences at the Case Western Reserve University School of Medicine, will take a different

Encrypted peptides, new class of antibiotics, offer hope in fight against antibiotic resistance

In a significant advance against the growing threat of antibiotic-resistant bacteria, , researchers have identified a novel class of antimicrobial agents known as encrypted peptides, which may expand the immune system’s arsenal of tools to fight infection.

Naked mole-rat has become the first mammalian to have waived infection-resistant proteins

Scientists have found that the naked mole-rat — an underground rodent that lives up to 40 years — has lost a number of CD1 functional genes. The CD1 gene family in mammals is responsible for protein synthesis that protects the body against infectious diseases. The findings indicate that the naked mole-rat’s immune system has significantly realigned and is using other — CD1-independent — molecular mechanisms. The results of the studies, supported by the Grants of Presidential program of the Russian Science Fund (RSF), were published in the Biology Direct magazine.

Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies – Developing Future Therapeutic Candidates with Broad Application Potential

Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.

Nanoparticles restore efficiency in exhausted immune cells killing cancer

A novel study led by Prof. Mira Barda-Saad and her research team at the Goodman Faculty of Life Sciences at Bar-Ilan University has unveiled a novel method to rejuvenate natural killer (NK) cells in the fight against cancer. The study, published on the cover of The EMBO Journal, addresses a critical challenge in cancer immunotherapy — NK cell exhaustion.

Targeting cancer with precision: neoantigen vaccines show promise

In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a formidable strategy in the battle against cancer. These vaccines, a testament to the power of personalized medicine, target cancer’s unique protein signatures, rallying the immune system for a precise and potent attack.

Study: Transplant Possible After Immunotherapy for Advanced Liver Cancer Patients

Liver transplant is considered the best treatment for liver cancer, but only available for patients with early-stage disease. Now a study led by Cedars-Sinai Cancer investigators has concluded that immunotherapy could make liver transplant an option for patients with later-stage cancer as well.

High Levels of a Specific Antibody May Contribute to Acute Coronary Syndrome

How a person’s immune system responds to a protein called LL-37 may increase risk for developing acute coronary syndrome, but the response may also serve as a potential target for future treatments.

Unlocking the immune system: cGAS-STING pathway offers new hope for cancer breakthroughs

A groundbreaking study has recognized the cGAS-STING signaling pathway as a formidable ally in the immune system’s battle against cancer. This pivotal discovery may pave the way for innovative immunotherapies capable of amplifying the body’s inherent defenses to detect and eradicate cancer cells, signifying a substantial advance towards more potent cancer treatments.

Short On Time? A 15-minute Workout May Help Boost Your Immune System 

Exercising at moderate intensity for just 15 minutes may be all that is needed to boost immunity by increasing levels of natural killer (NK) cells. Researchers will present their work this week at the American Physiology Summit in Long Beach, California.

LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.

Cancer researcher Miguel Reina-Campos, Ph.D., has joined the faculty of La Jolla Institute for Immunology (LJI) as an Assistant Professor to lead the Laboratory of Tissue Immune Networks. His laboratory at LJI aims to investigate the basis of CD8+ T cell tissue immunity to improve life-saving cancer immunotherapies.

Five Cutting-edge Advances in Biomedical Engineering and Their Applications in Medicine

Bridging precision engineering and precision medicine to create personalized physiology avatars. Pursuing on-demand tissue and organ engineering for human health. Revolutionizing neuroscience by using AI to engineer advanced brain interface systems. Engineering the immune system for health and wellness. Designing and engineering genomes for organism repurposing and genomic perturbations.

Army of specialized T cells may trigger asthma attacks in older men

LA JOLLA, CA—Scientists from La Jolla Institute for Immunology (LJI) and The University of Southampton, UK, have uncovered a group of immune cells that may drive severe asthma. These cells, called cytotoxic CD4+ tissue-resident memory T cells, gather in the lungs and appear to possess the molecular weaponry to cause the most harm in men who developed asthma later in life.

Long COVID patients show distinct immune, hormone responses to virus

People suffering from long COVID symptoms show different immune and hormonal responses to the virus that causes COVID-19, according to a new study led by researchers at Yale School of Medicine. An estimated 7.5% of people infected with the SARS-CoV-2…

Researchers find potential way to tweak immune system to help it fight tuberculosis

Tuberculosis is old—ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, but it hasn’t been cured yet. More than a million people around the world still die from TB every year.

Dr. Jaime Avila shares back-to-school tips that parents should know.

Jaime Avila, MD, at Baylor Scott & White McLane Children’s Medical Center, answers common patient questions and reacts to the latest medical research What can parents do to help ease back-to-school anxiety? (SOT@ :14, TRT :51) Some kids may not…

‘Tipping The Balance’ Of Immune Cells from Bad to Good Reverses Multiple Sclerosis Symptoms in Mice

According to the federal government’s National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide — with almost a third in the United States — are living with multiple sclerosis (MS), a disabling neurological disease in which the body’s immune system mistakenly attacks nerves feeding information to the central nervous system (the brain and spinal cord). Although rarely fatal, MS can lead to long-term disabilities, and impair movement, muscle control, vision and cognition.